Church & Dwight
CHD
$94.58
+0.46%
Church & Dwight Co., Inc. is a consumer defensive household and personal products company best known as the leading global producer of baking soda, with a portfolio spanning laundry products, cat litter, oral care, deodorant, and nasal care, sold primarily under the Arm & Hammer brand alongside Batiste, OxiClean, Hero, and TheraBreath. The company operates as a scaled, brand-led consumer staples platform rather than a high-growth disruptor, deriving roughly 80% of sales from the US market and generating about 70% of sales and profits from its five largest brands, with the fiscal 2025 addition of Touchland's hand sanitizer business extending its reach into higher-growth personal care. The current investor narrative centers on whether Church & Dwight can reaccelerate organic growth after a stretch of roughly flat top-line performance, with the most recent quarter showing revenue up only 0.15% year over year, while management leans on margin discipline, brand investment, and bolt-on M&A to offset soft volume trends. With the stock lagging the broader market over the past year and trading below its 52-week high, the debate has shifted toward valuation support, dividend durability, and whether new product innovation and acquisitions can restore mid-single-digit growth.…
CHD
Church & Dwight
$94.58
Investment Opinion: Should I buy CHD Today?
The synthesized recommendation is a Hold. Church & Dwight is a high-quality defensive staple with a solid dividend and low beta, but its stagnant revenue growth and premium valuation limit near-term upside. The analyst consensus rating of 'buy' with an average target price of $105.37 implies 11.9% upside, but the wide target range ($78 to $115) reflects significant uncertainty about the growth trajectory.
Supporting evidence for a Hold includes the company's strong free cash flow of $1.067 billion, which comfortably covers its dividend with a payout ratio of 38.98%, and its conservative balance sheet with a debt-to-equity ratio of 0.55. However, the forward PE of 23.31x is above the typical staples peer range of 18x-22x, and the PEG ratio of 1.01 suggests the stock is fairly valued relative to its expected growth. Revenue growth of just 0.15% year over year is a key concern, and while gross margin improved to 46.38% in Q1 2026, net margin declined to 14.72%. The stock's recent underperformance, down 7% in the past month versus a 1% decline for the S&P 500, further supports a cautious stance.
The biggest risks that could invalidate the Hold rating include a continued decline in organic growth, margin compression, and multiple contraction. The rating would upgrade to Buy if revenue growth accelerates above 3% and margins stabilize, or if the stock pulls back to the $85-$88 range, offering a more attractive entry point. Conversely, a downgrade to Sell would be warranted if revenue growth turns negative, margins deteriorate further, or if the company loses market share to competitors. Relative to its history, the stock is trading near the low end of its price-to-book range (5.08x versus a historical 5.0x-7.7x), suggesting it is fairly valued to slightly undervalued on that metric, but the premium on earnings multiples leaves little room for error.
Sign up to view all
CHD 12-Month Price Forecast
Church & Dwight presents a balanced risk/reward profile, with the bear case currently holding slightly more weight due to stagnant revenue growth and recent relative underperformance. The company's strong cash flow and low beta provide downside protection, but the premium valuation leaves little room for error. The key to the investment thesis is whether management can reignite organic growth through innovation and acquisitions; without it, the stock is likely to remain range-bound. I would upgrade to bullish if revenue growth accelerates above 3% and margins expand, and downgrade to bearish if revenue turns negative or margins compress further. The analyst consensus is moderately bullish, but the wide target range reflects genuine uncertainty.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Church & Dwight's 12-month outlook, with a consensus price target around $105.37 and implied upside of +11.4% versus the current price.
Average Target
$105.37
0 analysts
Implied Upside
+11.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$78 - $115
Analyst target range
Church & Dwight is covered by 19 analysts, with a consensus recommendation of "buy" and a recommendation mean of 2.24 on a scale where 1 is a strong buy and 5 is a strong sell, indicating a moderately bullish but not overwhelmingly enthusiastic stance. The average target price is $105.37, which implies approximately 11.9% upside from the current price of $94.15, while the estimated average EPS of $4.83 and estimated average revenue of $7.32 billion suggest analysts expect modest growth acceleration. The consensus leans bullish, but the distribution of institutional ratings shows a notable split: Wells Fargo and RBC Capital maintain Overweight/Outperform ratings, while UBS, JP Morgan, and Evercore ISI Group hold Neutral/In Line ratings and Barclays carries an Underweight rating, reflecting genuine disagreement about the growth outlook.
The full target price range spans from a low of $78.00 to a high of $115.00, a spread of $37.00 or roughly 39% of the current price, which signals high uncertainty and divergent views on the company's trajectory. The high target of $115.00 implies roughly 22% upside and likely assumes successful integration of recent acquisitions, a return to mid-single-digit organic growth, and multiple expansion as margins recover, while the low target of $78.00 implies roughly 17% downside and prices in continued revenue stagnation, margin compression, and potential multiple contraction toward the lower end of the staples peer group. The recent institutional ratings activity shows no upgrades or downgrades in the past six months, with all firms maintaining their prior positions, suggesting analysts are in a wait-and-see mode ahead of the next earnings catalyst. The wide target spread combined with the low beta of 0.472 and the 6.62 short ratio indicates that while the stock is defensively positioned, the lack of consensus on growth makes it susceptible to sharp moves in either direction depending on quarterly results.
Drowning in data?
Find the real signal!
Bulls vs Bears: CHD Investment Factors
The bear case currently has stronger evidence due to the company's stagnant revenue growth of just 0.15% year over year and recent relative underperformance, with the stock down 7% in the past month versus a 1% decline for the S&P 500. However, the bull case is supported by solid cash flow generation, a conservative balance sheet, and a low beta that appeals to defensive investors. The most important tension is whether Church & Dwight can reaccelerate organic growth to justify its premium valuation; without a return to mid-single-digit growth, the stock risks multiple compression. The analyst consensus target of $105.37 implies upside, but the wide range of targets ($78 to $115) underscores the lack of consensus on the growth trajectory. Ultimately, the investment thesis hinges on whether new product innovation and acquisitions like Touchland can revive top-line momentum.
Bullish
- Defensive low-beta staple: CHD's beta of 0.472 means it is roughly 53% less volatile than the broader market, making it an attractive holding during risk-off periods. The maximum drawdown of -14.82% over the past 180 days is modest compared to high-beta peers, and the stock has kept pace with the S&P 500 year-to-date with a +13.93% gain versus +12.08% for the index.
- Solid profitability and cash flow: The company generated $216.3 million in net income in Q1 2026, a 14.72% net margin, and $1.067 billion in trailing twelve-month free cash flow. This cash generation comfortably covers the $72.9 million quarterly dividend, with a payout ratio of only 38.98% and a dividend yield of 1.41%.
- Analyst consensus sees upside: The average analyst target price of $105.37 implies 11.9% upside from the current price of $94.15, with a consensus recommendation of 'buy' (mean rating 2.24). The high target of $115.00 suggests 22% upside if growth reaccelerates.
- Gross margin improvement: Q1 2026 gross margin improved to 46.38% from 44.96% in Q1 2025 and 42.95% in Q2 2025, showing successful cost management and pricing power. This margin expansion, if sustained, could drive earnings growth even without revenue acceleration.
Bearish
- Stagnant revenue growth: Q1 2026 revenue grew just 0.15% year over year to $1.469 billion, continuing a trend of flat top-line performance. The multi-quarter revenue pattern shows no acceleration, with Q4 2025 at $1.644 billion, Q3 2025 at $1.586 billion, and Q2 2025 at $1.506 billion, indicating a lack of organic momentum.
- Premium valuation without growth: The forward PE of 23.31x and EV/EBITDA of 17.04x are at a premium to typical consumer staples peers, which often trade at 18x-22x forward PE and 12x-15x EV/EBITDA. This premium is vulnerable to compression given the flat revenue trajectory.
- Recent relative underperformance: Over the past month, CHD declined 7.00% while the S&P 500 fell only 1.06%, a relative strength gap of -5.94 percentage points. Over six months, the stock is down 3.68% versus a 15.40% gain for the S&P 500, a -19.08 percentage point gap, indicating persistent weakness.
- Margin pressure: Despite gross margin improvement, net margin declined to 14.72% in Q1 2026 from 15.00% in Q1 2025, and operating margin slipped to 19.81% from 20.13%. This suggests that higher marketing or integration costs are offsetting gross margin gains.
CHD Technical Analysis
Church & Dwight is in a broad range-bound consolidation with a modest recovery bias, having posted a 1-year price change of -0.29% while the S&P 500 gained 16.22% over the same period, a relative strength gap of -16.51 percentage points. At the current price of $94.15, the stock sits roughly 12.8% below its 52-week high of $106.04 and about 15.8% above its 52-week low of $81.33, placing it near the middle of its 52-week range at approximately 56% of that band. This mid-range positioning signals neither momentum-driven overextension nor deep-value capitulation, but rather a market that is waiting for a fundamental catalyst before committing to a directional trend. The year-to-date gain of 13.93% versus the S&P's 12.08% shows the stock has actually kept pace in 2026, even as the trailing 12-month picture remains lackluster.
Recent momentum has deteriorated sharply, with the 1-month price change at -7.00% and the 3-month change at -3.50%, both well below the S&P's -1.06% and +3.04% respective moves, producing relative strength readings of -5.94 and -6.54 over those windows. The 6-month change of -3.68% versus the S&P's +15.40% reveals a persistent relative weakness that intensified in the most recent month, suggesting the late-summer rally toward $103.64 in early August has fully reversed. The stock peaked at $103.64 on August 5 and has since declined to $94.15, a roughly 9.2% drawdown from that recent high, with the pace of decline accelerating in the final week as the stock fell from $98.55 on September 4 to $94.15 by September 11. This divergence between the positive year-to-date trend and the negative 1-month and 3-month trends signals a potential trend reversal or at minimum a meaningful mean-reversion pullback within the broader range.
Key technical support rests at the 52-week low of $81.33, with intermediate support likely around the $92-$93 area where the stock found buyers in April and June 2026, while resistance is defined by the 52-week high of $106.04 and the recent swing high of $103.64. A breakout above $106.04 would signal a genuine trend change and likely require a fundamental catalyst such as an earnings beat or guidance raise, whereas a breakdown below $92 would open the door to a retest of the $81.33 low and confirm the bearish momentum. The stock's beta of 0.472 is notably low, indicating roughly 53% less volatility than the broader market, which makes it attractive for defensive positioning and income-oriented portfolios but also means it will likely underperform in strong risk-on rallies. The maximum drawdown of -14.82% over the period reflects this low-volatility profile, and the short ratio of 6.62 suggests a modest but not extreme level of bearish positioning.
Beta
0.47
0.47x market volatility
Max Drawdown
-14.8%
Largest decline past year
52-Week Range
$81-$106
Price range past year
Annual Return
+1.8%
Cumulative gain past year
| Period | CHD Return | S&P 500 |
|---|---|---|
| 1m | -6.6% | -2.0% |
| 3m | -3.9% | +1.4% |
| 6m | -1.2% | +15.0% |
| 1y | +1.8% | +15.7% |
| ytd | +14.4% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CHD Fundamental Analysis
Church & Dwight's revenue trajectory is essentially stagnant, with the most recent quarter (Q1 2026, ended March 31, 2026) generating $1.469 billion in revenue, up just 0.15% year over year from $1.467 billion in Q1 2025. The multi-quarter trend shows sequential revenue of $1.644 billion in Q4 2025, $1.586 billion in Q3 2025, $1.506 billion in Q2 2025, and $1.467 billion in Q1 2025, indicating a seasonal pattern with no clear acceleration, and the Q1 2026 print confirms that growth remains muted. The only disclosed segment, Specialty Products Division, contributed just $77 million, a small fraction of total revenue, meaning the core consumer brands are the primary growth engine and are currently delivering negligible expansion. For the investment case, this flat top-line profile implies that earnings growth must come from margin expansion, cost control, or acquisitions rather than organic revenue momentum, which limits the upside multiple the market is likely to award.
Profitability remains solid but is showing signs of pressure, with Q1 2026 net income of $216.3 million and a net margin of 14.72%, down from $220.1 million and a 15.00% net margin in Q1 2025. Gross margin in Q1 2026 was 46.38%, an improvement from 44.96% in Q1 2025 and 42.95% in Q2 2025, but the trailing twelve-month gross margin of 44.73% remains below the 47.12% peak seen in Q2 2024. Operating income fell to $291.0 million in Q1 2026 from $295.3 million a year earlier, with the operating margin slipping to 19.81% from 20.13%, while the TTM operating margin of 17.37% reflects the drag from the loss-making Q3 2024 period when the company reported a net loss of $75.1 million. The company remains comfortably profitable with a TTM net margin of 11.88%, but the modest compression in net and operating margins suggests that input costs, marketing investment, or acquisition integration costs are offsetting gross margin gains.
Church & Dwight's balance sheet is conservatively managed, with a debt-to-equity ratio of 0.55, a current ratio of 1.07, and a TTM free cash flow of $1.067 billion, which comfortably covers the $72.9 million in quarterly dividends paid in Q1 2026. The company generated $174.8 million in operating cash flow in Q1 2026 against $31.9 million in capital expenditures, yielding $142.9 million in free cash flow for the quarter, and it holds $503.4 million in cash at period end. Return on equity stands at 18.41% and return on assets at 7.87%, indicating efficient capital deployment, while the dividend payout ratio of 38.98% and dividend yield of 1.41% suggest the dividend is well covered and has room to grow. The primary financial risk is the elevated price-to-free-cash-flow ratio of 16.74 on a price-to-cash-flow basis and a TTM FCF yield of roughly 5.2%, which is reasonable for a staples company but leaves limited room for multiple expansion without improved cash generation.
Quarterly Revenue
$1.5B
2026-03
Revenue YoY Growth
+0.1%
YoY Comparison
Gross Margin
46.4%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CHD Overvalued?
Because Church & Dwight is solidly profitable with positive net income of $216.3 million in the most recent quarter and a trailing EPS of $0.036 (reflecting the TTM period including the Q3 2024 loss), the PE ratio is the appropriate primary metric, though the trailing PE of 27.58x is distorted by the loss quarter and the forward PE of 23.31x is the more meaningful gauge. The gap between the trailing PE of 27.58x and the forward PE of 23.31x implies the market expects earnings growth of roughly 18% over the next year, consistent with the analyst consensus EPS estimate of $4.83 versus the current run-rate, which is an optimistic assumption given the flat revenue trajectory. The PEG ratio of 1.01 suggests the stock is trading roughly in line with its expected growth rate, offering neither a clear value nor a clear growth premium at current levels.
Relative to the broader Consumer Defensive sector, Church & Dwight's forward PE of 23.31x and EV/EBITDA of 17.04x represent a premium to the typical staples peer group, where large-cap household products companies often trade in the 18x-22x forward PE range and 12x-15x EV/EBITDA range. The price-to-sales ratio of 3.28x and price-to-book ratio of 5.08x are elevated for a company with essentially flat revenue growth, and the EV/Sales of 3.93x reflects the market's willingness to pay up for the company's brand portfolio and consistent cash generation. This premium is partially justified by Church & Dwight's above-average ROE of 18.41%, its low beta of 0.472, and its reliable dividend, but the lack of top-line growth makes the premium vulnerable to compression if margins or cash flow disappoint.
Looking at the stock's own historical valuation range, the current forward PE of 23.31x is below the trailing PE readings of 25.6x in Q1 2026, 34.9x in Q4 2025, and 30.6x in Q1 2025, but above the 21.96x seen in Q3 2021 and the 23.19x in Q3 2022. The price-to-sales ratio of 3.28x is dramatically below the historical quarterly PS readings of 12x-18x reported in the historical ratios data, though those figures appear to use a different share count basis and are not directly comparable. On a price-to-book basis, the current 5.08x is near the low end of the 5.0x-7.7x range seen over the past five years, suggesting the stock is closer to the bottom of its historical valuation band than the top, which could represent a value opportunity if growth stabilizes or a warning if fundamentals continue to deteriorate.
PE
27.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 22x~39x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.0x
Enterprise Value Multiple
Investment Risk Disclosure
Church & Dwight faces financial and operational risks primarily stemming from its stagnant revenue growth, which grew only 0.15% year over year in Q1 2026. The company's net margin declined to 14.72% from 15.00% a year earlier, and operating margin slipped to 19.81% from 20.13%, indicating that cost pressures or increased marketing spend are eroding profitability. Additionally, the company relies heavily on its top five brands for about 70% of sales and profits, and derives roughly 80% of sales from the US market, creating concentration risk. While the balance sheet is conservative with a debt-to-equity ratio of 0.55 and $1.067 billion in trailing free cash flow, the flat top-line limits the company's ability to grow earnings without margin expansion or acquisitions.
Market and competitive risks include the stock's premium valuation relative to peers, with a forward PE of 23.31x and EV/EBITDA of 17.04x, which could compress if growth disappoints. The low beta of 0.472 means the stock may underperform in strong bull markets, as evidenced by its 16.51 percentage point underperformance versus the S&P 500 over the past year. Competitive threats in the household and personal products space are intense, with private-label brands and larger rivals like Procter & Gamble pressuring market share. Regulatory headwinds, such as potential changes in trade policies or ingredient regulations, could also impact costs. The short ratio of 6.62 indicates modest bearish sentiment, but any negative news could trigger a sharper decline given the stock's recent momentum deterioration.
In a worst-case scenario, a continued decline in organic growth, coupled with margin compression and multiple contraction, could drive the stock toward its 52-week low of $81.33 or the analyst low target of $78.00. From the current price of $94.15, that represents a downside of approximately 13.6% to the 52-week low and 17.2% to the analyst low target. If the company fails to integrate recent acquisitions successfully or if consumer spending weakens, the stock could retest these levels. The maximum drawdown over the past 180 days was -14.82%, but a more severe scenario could see a decline of 20% or more if earnings miss and guidance is cut.
FAQ
The key risks for CHD include: 1) Financial risk from stagnant revenue growth (0.15% YoY) and margin pressure, with net margin declining to 14.72% from 15.00%. 2) Competitive risk from private-label brands and larger rivals like Procter & Gamble, which could erode market share. 3) Macro risk from its low beta of 0.472, which may cause underperformance in strong bull markets, and sensitivity to consumer spending. 4) Company-specific risk from the wide analyst target range ($78-$115), reflecting uncertainty about growth prospects. The most severe risk is a continued decline in organic growth leading to multiple compression, which could drive the stock toward its 52-week low of $81.33.
Our 12-month forecast for CHD includes three scenarios: a bull case with 25% probability targeting $110-$115, a base case with 55% probability targeting $100-$106, and a bear case with 20% probability targeting $78-$85. The base case is most likely, assuming modest revenue growth of 1-2% and stable margins, with the stock trading around the analyst average target of $105.37. The bull case requires successful integration of Touchland and new product innovation driving mid-single-digit growth. The bear case would be triggered by negative revenue growth and margin compression, pushing the stock toward the 52-week low of $81.33.
CHD appears fairly valued to slightly overvalued on earnings multiples. The forward PE of 23.31x is above the typical consumer staples peer range of 18x-22x, and the EV/EBITDA of 17.04x is also at a premium. However, the PEG ratio of 1.01 suggests the stock is trading in line with its expected growth rate. On a price-to-book basis, the current 5.08x is near the low end of its historical 5.0x-7.7x range, indicating some value support. The market is pricing in an optimistic earnings growth of about 18% over the next year, which seems ambitious given flat revenue. Overall, the valuation implies the market expects a successful reacceleration of growth, leaving little margin for error.
Church & Dwight offers a mixed risk/reward profile. On the positive side, the stock has a low beta of 0.472, a solid dividend yield of 1.41%, and trades at an 11.9% discount to the analyst average target of $105.37. However, the company's revenue growth is stagnant at 0.15% year over year, and the forward PE of 23.31x is a premium to staples peers. The biggest downside risk is a retest of the 52-week low of $81.33, which would represent a 13.6% decline. For income-focused investors with a long-term horizon, CHD can be a good buy on dips, but growth-oriented investors may find better opportunities elsewhere. It is not a compelling buy at current levels given the lack of a near-term catalyst.
CHD is more suitable for long-term investment, given its defensive characteristics, low beta of 0.472, and reliable dividend yield of 1.41%. The company's stable cash flows and conservative balance sheet make it a good candidate for income-oriented portfolios. However, the lack of near-term growth catalysts and recent relative underperformance suggest limited short-term upside. Short-term traders might find opportunities around earnings announcements or technical levels, but the low volatility makes it less ideal for trading. A minimum holding period of 2-3 years is recommended to ride out growth cycles and benefit from dividend compounding.